EMIS Group (EMIS) Share Price, News & Analysis

Company Overview

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom. As of October 25, 2023, EMIS Group plc operates as a subsidiary of Optum Health Solutions (UK) Limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: 1,920 to 1,920
• 52-Week Range: N/A
• Volume: 433,828 shs
• Average Volume: 675,394 shs
• Market Capitalization: £1.23 billion
• P/E Ratio: 4,085.11
• Dividend Yield: 2.21%
• Price Target: N/A
• Consensus Rating: N/A

EMIS Stock Analysis - Frequently Asked Questions

How were EMIS Group's earnings last quarter?

EMIS Group plc (LON:EMIS) issued its quarterly earnings data on Wednesday, March, 14th. The company reported $47.20 EPS for the quarter, topping the consensus estimate of $46.30 by $0.90. The firm earned $160.35 million during the quarter. EMIS Group had a trailing twelve-month return on equity of 23.17% and a net margin of 17.23%.

How do I buy shares of EMIS Group?

Shares of EMIS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of EMIS Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EMIS Group investors own include RM (RM), Babcock International Group (BAB), The Character Group (CCT), Shire (SHP), BP (BP), Tullow Oil (TLW) and Vodafone Group Public (VOD).

Company Calendar

• Last Earnings: 3/14/2018
• Today: 5/01/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: LON:EMIS
• CIK: N/A
• Web: www.emisgroupplc.com
• Phone: +44-113-3803000
• Fax: N/A
• Employees: 1,560
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.47
• Trailing P/E Ratio: 4,085.11
• Forward P/E Ratio: N/A
• P/E Growth: 1.37
• Net Income: £30.48 million
• Net Margins: 17.23%
• Pretax Margin: N/A
• Return on Equity: 23.17%
• Return on Assets: 7.99%

Debt

• Debt-to-Equity Ratio: 2.96
• Current Ratio: 1.07
• Quick Ratio: 1.83

Sales & Book Value

• Annual Sales: £176.86 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 21.90
• Book Value: GBX 210 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 64,160,000
• Free Float: N/A
• Market Cap: £1.23 billion
• Optionable: Not Optionable
• Beta: -0.13